Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome. The structure of full-length retroviral integrase, either separately or in complex with DNA, has been lacking. Furthermore, although clinically useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative. Here we present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA. The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly associated with a pair of viral DNA ends. All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions. The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex. Our findings define the structural basis of retroviral DNA integration, and will allow modelling of the HIV-1 intasome to aid in the development of antiretroviral drugs.
Retroviral integrase (IN) recognizes and acts on the termini of the linear double-stranded DNA molecule that is produced by reverse transcription 1, 2 . Initially, in a reaction termed 39-processing, IN removes two or three nucleotides from one or both viral DNA ends to expose the 39 hydroxyl groups of the invariant CA dinucleotides. Next, after import of the viral DNA into the nucleus, IN inserts both 39 ends of the viral DNA into opposing strands of cellular genomic DNA. Mechanistically and structurally, IN belongs to a diverse family of polynucleotidyl transferases 3 , which notably includes RNaseH 4 and the transposases from Tn5 (ref. 5 ) and eukaryotic mobile element Mos1 (ref. 6) (reviewed in refs 7, 8) . The reactions catalysed by these enzymes proceed by S N 2-type nucleophilic substitution, assisted by divalent metal cofactors 4,9 . In retroviral IN, a pair of divalent metal cations (Mg 21 or Mn 21 ) are thought to be coordinated by three carboxylates of the invariant D,D-35-E motif within the catalytic core domain (CCD). To function, IN also requires its amino-terminal domain (NTD), a three-helical bundle stabilized by binding a Zn atom, and a carboxy-terminal domain (CTD) that adopts an SH3-like fold 10, 11 . In vivo, IN acts within a large nucleoprotein complex that contains viral DNA and several virus-and hostcell-derived components. The minimal functional complex involving viral DNA and IN, referred to here as the intasome, can be assembled in vitro from purified components 12 .
Despite its acute importance for antiretroviral drug discovery and decades of rigorous research 7, 13 , the complete structure of IN, either as a separate protein or in the context of the functional intasome, is lacking. Accordingly, the structural organization of the enzyme active site, which is believed to adopt its functional state only after viral DNA binding, is unknown. Because clinically useful HIV-1 IN strand-transfer inhibitors 14, 15 (InSTIs) preferentially bind to and inhibit the intasome complex as compared to free IN 16 , the mechanism of drug action is poorly understood. We have now obtained diffracting crystals of the full-length IN from the prototype foamy virus (PFV) in complex with its cognate viral DNA. The availability of these crystals enabled us to determine the long-sought structure of the retroviral intasome and explain the mechanism of strand-transfer inhibitor action.
Crystallization of the PFV intasome
Most characterized INs predominantly promote the insertion of one viral DNA end into one strand of a target DNA duplex in vitro. In contrast, we recently reported that recombinant PFV IN catalyses efficient concerted insertion of two PFV DNA ends into target DNA 17 . Here, we obtained soluble and fully functional PFV intasome preparations using recombinant PFV IN and double-stranded oligonucleotides that mimic the viral DNA ends ( Supplementary Fig. 1 ). To bypass the initial catalytic step, 39-processing, the IN-DNA complexes were assembled using 'pre-processed' oligonucleotides with recessed termini, which model the viral DNA ends before their insertion into host chromosomal DNA. The IN-DNA complexes were remarkably stable and did not dissociate or lose activity, even after prolonged incubations under high ionic strength conditions (Supplementary Fig. 1 and data not shown).
After extensive crystallization trials we identified a crystal form of full-length wild-type PFV IN in complex with a 19-base-pair (bp) donor DNA that diffracted X-rays to 2.9 Å resolution, enabling us to determine the three-dimensional structure of the intasome (Supplementary Table 1 ). The asymmetric unit contained a single IN dimer with a tightly associated viral DNA molecule, and a pair of symmetry-related IN dimers formed an oblong tetramer (130 3 65 3 70 Å ; Fig. 1a and Supplementary Movie 1). The IN dimer-dimer interface is stabilized by intermolecular NTD-CCD interactions, as previously observed in partial structures of lentiviral INs 18, 19 . The overall shape of the tetramer is reminiscent of the low-resolution envelope obtained by a recent negative-stain electron microscopy study of HIV-1 IN complexes 20 . Nonetheless, its architecture is markedly different from all previously reported models.
Overall architecture of the PFV intasome The inner subunits of the tetramer (coloured green and blue in Fig. 1 ) are responsible for all contacts involved in tetramerization and viral DNA binding. The CCDs of the outer subunits (gold in Fig. 1 ) seem to provide supporting function, their NTDs and CTDs not resolved in the electron density maps. Previous retroviral IN CCD structures showed a conserved dimeric interface 7 , and this interface is retained between the inner and outer IN subunits of the intasome. Partial structures of INs from HIV-1 (ref. 21) , simian immunodeficiency 22 and Rous sarcoma 23 viruses showed considerable variability of the CCD-CTD linker region. Within the PFV intasome, the CCD-CTD linker adopts an extended conformation for most of its length, tracking parallel to the NTD-CCD linker from the same subunit (Fig. 1b ). The interdomain linkers truss both halves of the intasome together, and the structure is further stabilized by a pair of CTDs interacting with both inner CCDs ( Fig. 1a ), in addition to an extensive network of protein-DNA interactions (see later). Thus, in contrast to previous IN tetramer models based on two domain structures in which the dimer-dimer interface appeared highly flexible 18, 19 , the overall conformation of the assembled intasome is well constrained. Homology modelling suggests that the notably shorter interdomain linkers in HIV-1 IN ( Supplementary Fig. 2 ) can extend sufficiently to allow a similar overall architecture and topology in the HIV-1 intasome (data not shown). A further small domain, which we refer to as the NTD extension domain (NED), precedes the PFV IN NTD (Fig. 1b ). On the basis of amino acid sequence comparisons and secondary structure predictions, NEDs are present in other spumaviral and possibly gammaretroviral INs (data not shown).
IN-DNA interactions within the PFV intasome
In total, almost 10,000 Å 2 of molecular surface is buried within IN-DNA interfaces of the intasome. The protein-DNA interactions involve amino acid residues from each domain of the inner IN subunits, their interdomain linkers, and 17 nucleotides from each viral DNA end ( Supplementary Figs 2 and 3) . Thus, as observed in the case of Tn5 transposase 5 , the canonical retroviral IN domains (NTD, CCD and CTD) do not have discrete functions; each contributes to extensive protein-protein and protein-DNA contacts within the functional complex. The most intimate protein-DNA interactions are found within the terminal six nucleotides, where the viral DNA deviates considerably from the ideal B form. Each CTD makes contact with the phosphodiester backbone of both viral DNA molecules, essentially crosslinking the structure. Notably, the NED and NTD of each catalytic subunit interact with the viral DNA molecule engaged at the active site of the opposing CCD (Fig. 1a ). The NED interacts with the phosphodiester backbone, whereas the other elements (NTD, CTD, CCD, NTD-CCD and CCD-CTD linkers) further contribute to interactions with DNA bases. These sequence-specific interactions include the main-chain carbonyl group of Gly 218, which forms a hydrogen bond with guanine 4 of the non-transferred strand (Fig. 2a ). The protein-DNA interactions extend into the beginning of the CCD a4 helix, which packs into the minor groove at the end of the viral DNA duplex ( Fig. 2a and Supplementary Fig. 3 ). The side chain of Arg 222 is involved in hydrogen bonding with T5 and C6 bases of the nontransferred strand ( Fig. 2a ). Another set of sequence-specific contacts involves residues from the NTD-CCD and CCD-CTD linkers extending from the opposing IN dimer. The side chain of Arg 313 intercalates the minor groove of viral DNA, stacking its guanidinium group against adenosine 12 of the reactive strand and forming a hydrogen bond with cytosine 11 (Fig. 2b) . Nearby, the side chain of Asn 106 interacts with thymine 8 of the non-transferred strand. These interactions cause notable widening of the minor groove of the viral DNA ( Fig. 2b and Supplementary Fig. 3b ). The overall extent of the protein-DNA interaction agrees well with the ,16 bp IN footprint in functional HIV-1 intasomes 12 .
At the reactive viral DNA terminus, the base pair involving the cytosine of the invariant CA dinucleotide (C16 and A17 of the reactive strand; Supplementary Fig. 3a ) is distorted by a buckle of ,30u, whereas the terminal adenine is completely isolated from its complement on the non-transferred strand (Fig. 2a ). The active-site loop (PFV IN residues 211-220) is directly involved in separating the viral DNA strands, acting as a plough with highly conserved residues Pro 214 and Gln 215 (corresponding to HIV-1 Pro 145 and Gln 146, see Supplementary Fig. 2 for PFV/HIV-1 structure-based alignment) forming its share. In particular, Gln 215 displaces thymine 3 of the non-transferred strand, which turns away from the interior of the DNA duplex ( Fig. 2a and Supplementary Fig. 3b ). The 59-overhang of the non-transferred strand is threaded between the CCD and interdomain linkers, where it forms extensive contacts with the active-site loop and the CTD from the same IN chain ( Supplementary Fig. 3c ). The involvement of the CCD a4 helix and the active-site loop in intimate interactions with the viral DNA end agrees well with results of chemical and photo crosslinking of functional HIV-1 IN-DNA complexes [24] [25] [26] .
The active site of the functional intasome The reactive 39 termini of the donor DNA molecules are positioned within close proximity of the Asp 128, Asp 185 and Glu 221 activesite carboxylates (Fig. 2a ). Although the crystals could be grown in the presence of MgCl 2 , which considerably improved their diffraction limit ( Supplementary Table 1 ), data resolution did not allow unambiguous visualization of Mg 21 cations in the active site.
Fortuitously, similar to other retroviral INs 1 , PFV IN can efficiently use Mn 21 , a more electron-rich element, as a metal ion cofactor ( Supplementary Fig. 1d) . A difference electron density map calculated using diffraction data collected on crystals soaked in the presence of MnCl 2 revealed two strong positive peaks (9.4 and 12.4s) within the active sites of the inner IN subunits. This result confirmed the expected two-metal binding mode of retroviral INs and revealed the positions of metal ion cofactors within the assembled active site, which could be refined at full occupancy (Fig. 3a , see also Supplementary  Fig. 4a for metal atom omit and final electron density maps). On the basis of the current model for two-metal active-site catalysis 4 , metal atom B, coordinated by the carboxylates of Asp 128 and Glu 221, is in place to activate the 39 hydroxyl group of the pre-processed viral DNA for strand transfer, whereas metal A, bound by Asp 128 and Asp 185, would be expected to destabilize the scissile phosphodiester group in target DNA. Superposition of the Ca atoms of the active-site Asp and Glu residues showed notable conservation between the metal and DNA substrate binding modes of the Tn5 synaptic complex 27 and PFV intasome ( Supplementary Fig. 5 ). Furthermore, the positions of the metal ions are nearly identical to those of Cd 21 and Zn 21 cations observed in structures of the avian sarcoma virus IN CCD 28 . Of note, soaking crystals in MgCl 2 or MnCl 2 did not change the organization of the intasome active site ( Supplementary Fig. 6 ). Hence, the positioning of the 39 end of viral DNA is independent of bound divalent metal ions.
Model for target DNA binding
The active sites of the inner IN subunits, engaged with the 39 termini of the viral DNA, are located deep within the dimer-dimer interface. Therefore, the only mode of host chromosomal DNA (target DNA) binding that would not require marked rearrangement of the intasome or severe DNA bending is along the cleft between IN dimers (Fig. 4 ). This target DNA binding mode could not have been predicted based on previous partial IN structures, and starkly differs from what we recently proposed 18 . Modelling B-form DNA within the cleft results in near perfect alignment of the active sites with opposing target DNA phosphodiester bonds separated by 4 bp, the known spacing of concerted PFV integration 17 . It is easy to see how mutations within the a2 helix of the CCD, described in ref. 29 , would prevent target DNA binding (Fig. 4) . We tentatively speculate that the NTDs and/or the CTDs of the outer IN subunits, disordered in our structures, could be involved in target DNA capture 30 . However, this target-binding model requires verification using mutagenesis or crystallographic approaches.
Mechanism for strand-transfer inhibitor action
We have previously shown that PFV IN is sensitive to HIV-1 InSTIs 17 . These compounds are thought to engage metal ion cofactors in the IN active site by interactions with uniquely positioned oxygen atoms of the pharmacophore 31 . The role of the remaining common InSTI feature, a fluorobenzyl group, is enigmatic. Intasome structure refinement using diffraction data collected on crystals soaked in the presence of Mg 21 and the clinical InSTI MK0518 (also known as raltegravir) 14 or GS9137 (elvitegravir) 15 showed strong further electron density within the active sites of the inner IN subunits. Structures of MK0518 or GS9137 with pairs of Mg atoms could be easily fitted into the maps and refined to 2.85 and 3.15 Å resolution, respectively (Fig. 3b, c, Supplementary Fig. 4d, f and Supplementary  Table 1 ). Moreover, soaking crystals in the presence of the drugs and Mn 21 produced similar results, with manganese atoms and drug molecules refining at almost precisely the same positions ( Supplementary Fig. 4b, c, e, g) . Concordantly, InSTIs inhibited both the Mg 21 -and Mn 21 -dependent activities of the PFV intasome ( Supplementary Fig. 1d ).
On the basis of the structures, the two InSTIs seem to have very similar modes of binding and action, involving an induced fit mechanism. Their metal chelating oxygen atoms orient towards the metal cofactors of the active site, whereas their halobenzyl groups fit within a tight pocket created by displacement of the 39 adenosine (A17). Within it, the drugs make intimate Van der Waals interactions with the bases of the invariant CA dinucleotide, guanine 4 from the nontransferred strand, and conserved residues Pro 214 and Gln 215 (Fig. 3b, c) . In addition, the isopropyl and methyl-oxadiazole groups of MK0518 are involved in hydrophobic and stacking interactions with the side chains of Pro 214 and Tyr 212, respectively (Fig. 3b) , further stabilizing this drug in the active site. Through its quinolone base and isopropyl group, GS9137 interacts with Pro 214 (Fig. 3c) . Crucially, this mode of drug binding results in displacement of the reactive 39 viral DNA end from the active site (Fig. 3b, c) , which can only result in deactivation of the intasome. Thus, after binding of MK0518, the reactive 39 hydroxyl group moves away from the active site by more than 6 Å , compared to its positions in the Mg 21 -or Mn 21 -containing, or apo crystals. Because the core contact points consisting of invariant nucleotide bases and amino acid residues are conserved in HIV-1, the mode of InSTI binding and action are unlikely to significantly differ. The extensive contacts with the viral DNA end observed in our structures determine why the InSTIs preferentially interact with and inhibit the DNA-bound form of HIV-1 IN 16 . Moreover, the induced fit caused by displacement of the 39 adenosine by the halobenzyl groups of these compounds explains why the deletion of this base markedly increased InSTI on-and off-rates for binding to HIV-1 IN-DNA complexes 32 .
Furthermore, mutations of HIV-1 IN residue Tyr 143, which, on the basis of our structure, is expected to interact with the methyloxadiazole group of MK0518 ( Fig. 3b and Supplementary Fig. 2) , are known to confer resistance to this drug 33 . Common InSTI resistance pathways involve mutations of HIV-1 IN Gln 148 or Asn 155 (ref. 33) , which correspond to PFV IN residues Ser 217 and Asn 224, respectively ( Supplementary Fig. 2 ). Mutations at these positions are likely to interfere with coordination of metal cofactors by the activesite carboxylates, as proposed recently 34 . Conceivably, a slight shift in metal ion cofactor positions might suffice to abrogate drug binding, which relies on its spatially constrained metal chelating groups, albeit at a steep price of impaired viral replication fitness due to detuning of the IN active site structure.
Our findings will allow the generation of reliable HIV-1 IN and InSTI pharmacophore models, which will be invaluable for the development of next-generation strand-transfer inhibitors. Their design should take advantage of the most conserved elements of the IN active site determined here, such as the bases of the invariant CA dinucleotide, positions of the metal co-factors and the mainchain atoms of the protein.
METHODS SUMMARY
Protein-DNA complexes were assembled using full-length wild-type PFV IN 17 and synthetic double-stranded DNA that modelled the viral U5 end (59-TACAAAATTCCATGACA-39/59-ATTGTCATGGAATTTTGTA-39) by dialysis, reducing the NaCl concentration from 500 to 200 mM. A typical result of complex assembly is shown in Supplementary Fig. 1a . The intasome was crystallized by vapour diffusion in hanging drops with a reservoir solution containing 1.35 M ammonium sulphate, 25% (v/v) glycerol, 4.8% (v/v) 1,6-hexanediol and 50 mM 2-(N-morpholino) ethanesulphonic acid (MES), pH 6.5. The crystals were soaked in the presence of MK0518, GS9137, Mg 21 and/or Mn 21 , as required. Diffraction data were obtained at the beamlines I02 and I04 of the Diamond Light Source (Oxford, UK), and the structure was solved by molecular replacement. Crystallographic and refinement statistics for the seven resulting models are summarized in Supplementary Table 1 . The structures, refined to Fig. 1a with active-site side chains shown as red sticks and a2 helices, known to contribute to target DNA binding 29 , in cyan. The DNA molecule modelled in black and grey shows the most likely orientation for target DNA binding. Note that the CTD, juxtaposed to the target DNA in this model, is known to possess sequence non-specific DNA binding activity 35 . 2.85-3.25 Å resolution, included PFV IN residues 10-374 and 116-278 in chains A and B, respectively, without gaps, and both complete strands of the preprocessed donor DNA molecule (17 and 19 nucleotides in chains C and D, respectively). The models had good geometry with 92.2-96.4 and not more than 0.4% of amino acid residues in most preferred and disallowed regions of the Ramachandran plot, respectively.
